For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Regulus Therapeutics Inc (NASDAQ: RGLS) closed at $1.41 down -4.08% from its previous closing price of $1.47. In other words, the price has decreased by -$4.08 from its previous closing price. On the day, 0.5 million shares were traded. RGLS stock price reached its highest trading level at $1.4899 during the session, while it also had its lowest trading level at $1.38.
Ratios:
For a deeper understanding of Regulus Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.65 and its Current Ratio is at 13.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $7.
On March 18, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $6.
On March 28, 2018, B. Riley FBR Inc. started tracking the stock assigning a Neutral rating and target price of $1.B. Riley FBR Inc. initiated its Neutral rating on March 28, 2018, with a $1 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 25 ’24 when Collier Kathryn J bought 4,000 shares for $1.82 per share. The transaction valued at 7,280 led to the insider holds 6,740 shares of the business.
CALSADA CRISPINA sold 5,468 shares of RGLS for $6,510 on Jan 18 ’24. The Chief Financial Officer now owns 5,782 shares after completing the transaction at $1.19 per share. On Jan 18 ’24, another insider, Aker Christopher Ray, who serves as the Sr. VP & General Counsel of the company, sold 5,468 shares for $1.19 each. As a result, the insider received 6,510 and left with 10,056 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGLS now has a Market Capitalization of 92355136 and an Enterprise Value of 6291189.
Stock Price History:
Over the past 52 weeks, RGLS has reached a high of $3.79, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -8.98%, while the 200-Day Moving Average is calculated to be -24.69%.
Shares Statistics:
For the past three months, RGLS has traded an average of 355.31K shares per day and 645140 over the past ten days. A total of 65.50M shares are outstanding, with a floating share count of 52.92M. Insiders hold about 19.21% of the company’s shares, while institutions hold 77.29% stake in the company. Shares short for RGLS as of 1728950400 were 2500563 with a Short Ratio of 7.04, compared to 1726185600 on 3292534. Therefore, it implies a Short% of Shares Outstanding of 2500563 and a Short% of Float of 4.8499998.
